(Q45796745)

16 December 2017

http://europepmc.org/abstract/MED/6324457

title

Production of monoclonal antibody to a late intracellular Epstein-Barr virus-induced antigen (English)

1 reference

https://api.crossref.org/works/10.1016/0042-6822(84)90402-1

28 September 2023

0 references

1 reference

M. Kishishita

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6324457

28 September 2023

J. Luka

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6324457

28 September 2023

B. Vroman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6324457

28 September 2023

J. F. Poduslo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6324457

28 September 2023

G. R. Pearson

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6324457

28 September 2023

language of work or name

English

0 references

publication date

1 March 1984

1 reference

16 December 2017

http://europepmc.org/abstract/MED/6324457

full work available at URL

https://api.elsevier.com/content/article/PII:0042682284904021?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0042-6822(84)90402-1

https://api.elsevier.com/content/article/PII:0042682284904021?httpAccept=text/plain

28 September 2023

1 reference

https://api.crossref.org/works/10.1016/0042-6822(84)90402-1

28 September 2023

1 reference

16 December 2017

http://europepmc.org/abstract/MED/6324457

volume

133

1 reference

16 December 2017

http://europepmc.org/abstract/MED/6324457

issue

2

1 reference

16 December 2017

http://europepmc.org/abstract/MED/6324457

page(s)

363-375

1 reference

16 December 2017

http://europepmc.org/abstract/MED/6324457

cites work

The Regulated Expression of Epstein--Barr Virus. III. Proteins Specified by EBV During the Lytic Cycle

2

1 reference

https://api.crossref.org/works/10.1016/0042-6822(84)90402-1

Detection of virus-specific antigens in EB-(P3HR1) virus-superinfected Raji cells by immunoprecipitation

28 September 2023

3

1 reference

https://api.crossref.org/works/10.1016/0042-6822(84)90402-1

Fractionation of asparagine-linked oligosaccharides by serial lectin-Agarose affinity chromatography. A rapid, sensitive, and specific technique

28 September 2023

4

1 reference

https://api.crossref.org/works/10.1016/0042-6822(84)90402-1

Epstein-Barr virus polypeptides: effect of inhibition of viral DNA replication on their synthesis

28 September 2023

6

1 reference

https://api.crossref.org/works/10.1016/0042-6822(84)90402-1

Membrane antigen expression in Epstein-Barr virus-infected Raji cells in the presence of phosphonoacetic acid

28 September 2023

7

1 reference

https://api.crossref.org/works/10.1016/0042-6822(84)90402-1

Immunochemical Characterization of Epstein-Barr Virus-Associated Early and Late Antigens in n -Butyrate-Treated P3HR-1 Cells

28 September 2023

9

1 reference

https://api.crossref.org/works/10.1016/0042-6822(84)90402-1

Epstein-Barr virus-induced polypeptides: A comparative study with superinfected Raji, IUdR-treated, and n-butyrate-treated P3HR-1 cells

28 September 2023

10

1 reference

https://api.crossref.org/works/10.1016/0042-6822(84)90402-1

The structural basis of the different affinities of two types of acidic N-glycosidic glycopeptides for concanavalin A--sepharose

28 September 2023

12

1 reference

https://api.crossref.org/works/10.1016/0042-6822(84)90402-1

A sensitive Enzyme-Linked Immunosorbent Assay (ELISA) against the major EBV-associated antigens. I. Correlation between ELISA and immunofluorescence titers using purified antigens

28 September 2023

13

1 reference

https://api.crossref.org/works/10.1016/0042-6822(84)90402-1

The Epstein-Barr Virus-Determined Nuclear Antigen: a Previously Identified 48K Component and Higher-Molecular-Weight Forms of the Antigen Are Structurally Related

28 September 2023

14

1 reference

https://api.crossref.org/works/10.1016/0042-6822(84)90402-1

Purification of the Epstein-Barr virus-determined nuclear antigen from Epstein-Barr virus-transformed human lymphoid cell lines

28 September 2023

15

1 reference

https://api.crossref.org/works/10.1016/0042-6822(84)90402-1

Purification and Properties of the gp340 Component of Epstein--Barr Virus Membrane Antigen in an Immunogenic Form

28 September 2023

16

1 reference

https://api.crossref.org/works/10.1016/0042-6822(84)90402-1

Analysis of early and late Epstein-Barr virus associated polypeptides by immunoprecipitation

28 September 2023

17

1 reference

https://api.crossref.org/works/10.1016/0042-6822(84)90402-1

Observations on the EB virus envelope and virus-determined membrane antigen (MA) polypeptides

28 September 2023

18

1 reference

https://api.crossref.org/works/10.1016/0042-6822(84)90402-1

Fractionation of Glycopeptides by Affinity Column Chromatography on Concanavalin A-Sepharose1

28 September 2023

19

1 reference

https://api.crossref.org/works/10.1016/0042-6822(84)90402-1

Identification of polypeptide components of the Epstein-Barr virus early antigen complex with monoclonal antibodies

28 September 2023

22

1 reference

https://api.crossref.org/works/10.1016/0042-6822(84)90402-1

Identification of Epstein-Barr virus strain differences with monoclonal antibody to a membrane glycoprotein

28 September 2023

23

1 reference

https://api.crossref.org/works/10.1016/0042-6822(84)90402-1

Epstein-Barr virus-induced membrane antigens: Immunochemical characterization of triton X-100 solubilized viral membrane antigens from EBV-superinfected raji cells

28 September 2023

25

1 reference

https://api.crossref.org/works/10.1016/0042-6822(84)90402-1

Radioimmune precipitation study comparing the epstein-barr virus membrane antigens expressed on P3HR-1 virus-superinfected Raji cells to those expressed on cells in a B-95 virus-transformed producer culture activated with tumor-promoting agent (TPA)

28 September 2023

26

1 reference

https://api.crossref.org/works/10.1016/0042-6822(84)90402-1

Correlation Between Epstein-Barr Virus Membrane Antigen and Three Large Cell Surface Glycoproteins

28 September 2023

28

1 reference

https://api.crossref.org/works/10.1016/0042-6822(84)90402-1

Production and characterization of monoclonal antibodies against the Epstein-Barr virus membrane antigen

28 September 2023

30

1 reference

https://api.crossref.org/works/10.1016/0042-6822(84)90402-1

Monoclonal antibody specific for capsid antigen of Epstein-Barr virus

28 September 2023

31

1 reference

https://api.crossref.org/works/10.1016/0042-6822(84)90402-1

Epstein-Barr Virus Antigens–A Challenge to Modern Biochemistry

28 September 2023

32

1 reference

https://api.crossref.org/works/10.1016/0042-6822(84)90402-1

Polypeptides of the Epstein-Barr virus membrane antigen complex

28 September 2023

33

1 reference

https://api.crossref.org/works/10.1016/0042-6822(84)90402-1

Monoclonal antibodies against the major glycoprotein (gp350/220) of Epstein-Barr virus neutralize infectivity

28 September 2023

34

1 reference

https://api.crossref.org/works/10.1016/0042-6822(84)90402-1

28 September 2023

Identifiers

1 reference

16 December 2017

http://europepmc.org/abstract/MED/6324457

1 reference

16 December 2017